GWM
EXEL icon

Geneos Wealth Management’s Exelixis EXEL Stock Holding History

Geneos Wealth Management’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,781
Closed -$78.5K – 2721
2025
Q2 		$78.5K Buy
1,781
+134
+8% +$5.36K ﹤0.01% 1353
2025
Q1 		$60.8K Buy
1,647
+944
+134% +$33.6K ﹤0.01% 1385
2024
Q4 		$23.4K Buy
703
+166
+31% +$5.38K ﹤0.01% 1657
2024
Q3 		$13.9K Buy
+537
New +$13.3K ﹤0.01% 1704
2022
Q3 		– Sell
-495
Closed -$10K – 2194
2022
Q2 		$10K Hold
495
– – ﹤0.01% 1939
2022
Q1 		$11K Hold
495
– – ﹤0.01% 2041
2021
Q4 		$9K Sell
495
-414
-46% -$7.92K ﹤0.01% 2210
2021
Q3 		$19K Hold
909
– – ﹤0.01% 1936
2021
Q2 		$16K Hold
909
– – ﹤0.01% 2014
2021
Q1 		$22K Hold
909
– – ﹤0.01% 2027
2020
Q4 		$20K Buy
909
+414
+84% +$8.67K ﹤0.01% 1906
2020
Q3 		$11K Hold
495
– – ﹤0.01% 1911
2020
Q2 		$11K Hold
495
– – ﹤0.01% 1871
2020
Q1 		$8K Hold
495
– – ﹤0.01% 1883
2019
Q4 		$8K Hold
495
– – ﹤0.01% 2044
2019
Q3 		$8K Hold
495
– – ﹤0.01% 1959
2019
Q2 		$10K Hold
495
– – ﹤0.01% 1903
2019
Q1 		$11K Sell
495
-1,000
-67% -$22.8K ﹤0.01% 1803
2018
Q4 		$29K Buy
1,495
+1,000
+202% +$17.8K ﹤0.01% 1340
2018
Q3 		$8K Sell
495
-1,185
-71% -$23.1K ﹤0.01% 1917
2018
Q2 		$36K Buy
1,680
+185
+12% +$3.83K ﹤0.01% 1200
2018
Q1 		$33K Hold
1,495
– – ﹤0.01% 1183
2017
Q4 		$45K Buy
1,495
+217
+17% +$5.77K ﹤0.01% 1042
2017
Q3 		$30K Hold
1,278
– – ﹤0.01% 1167
2017
Q2 		$31K Sell
1,278
-1,488
-54% -$31.5K ﹤0.01% 1108
2017
Q1 		$59K Buy
2,766
+1,741
+170% +$35.4K 0.01% 825
2016
Q4 		$15K Buy
1,025
+105
+11% +$1.51K ﹤0.01% 1292
2016
Q3 		$13K Hold
920
– – ﹤0.01% 1273
2016
Q2 		$7K Buy
+920
New +$5.3K ﹤0.01% 1423

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geneos Wealth Management's EXEL Position: Q3 2025 in Review

Geneos Wealth Management sold out of Exelixis (EXEL) in Q3 2025, closing a stake of 1,781 shares — an estimated $78.5K sold.

Geneos Wealth Management first reported a position in EXEL in Q2 2016 and held it in 29 quarters. The position peaked at $78.5K in Q2 2025. 621 funds tracked by Wall St. Rank hold EXEL as of Q3 2025.

  • Geneos Wealth Management reported no remaining Exelixis position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 1,781 Exelixis shares in Q3 2025, an estimated $78.5K.
  • Geneos Wealth Management first reported a position in Exelixis in Q2 2016 and held it in 29 quarters.
  • Geneos Wealth Management's Exelixis position peaked at $78.5K in Q2 2025.
  • 621 funds tracked by Wall St. Rank held Exelixis as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.